Puma Biotechnology Q2 Loss Narrows - Quick Facts

(RTTNews) - Puma Biotechnology, Inc. (PBYI) Tuesday said second-quarter loss narrowed to $12.6 million or $0.44 per share from $14.8 million or $0.74 per share in the comparable quarter last year.

Adjusted loss for the quarter was $10.9 million or $0.38 per share. On average, four analysts polled by Thomson Reuters expected the company to report a loss of $0.43 per share for the quarter. Analysts' estimates typically exclude special items.

Operating expenses decreased to $12.7 million from $14.8 million. Research and development expenses totaled $10.4 million, down from $13.0 million last year.